BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 995407)

  • 1. Carbon tetrachloride toxicity in the rat after administration of hypolipidemic agents.
    Burdino E; Crispino A; Di Carlo R; Genazzani E; Pagliarani M; Reboani C; Ugazio G
    Panminerva Med; 1976; 18(11-12):410-4. PubMed ID: 995407
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of hypolipidemic drug clofibrate in altering iron regulatory proteins IRP1 and IRP2 activities and hepatic iron metabolism in rats fed a low-iron diet.
    Huang HL; Shaw NS
    Toxicol Appl Pharmacol; 2002 Apr; 180(2):118-28. PubMed ID: 11969379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypolipidemic activity of Indan--1--acetic acids.
    Adak M; Gupta JK
    Nepal Med Coll J; 2006 Mar; 8(1):22-6. PubMed ID: 16827085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of hypolipidemic peroxisome proliferators in the lymphocyte [3H]thymidine and Salmonella mutagenesis assays.
    Warren JR; Simmon VF; Reddy JK
    Cancer Res; 1980 Jan; 40(1):36-41. PubMed ID: 6765917
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined effects of ethyl-alpha-p chlorphenoxyisobutyrate (CPIB) and carbon tetrachloride on the rat liver cells.
    Temcharoen P; Bunyaratvej S; Bhamarapravati N
    J Med Assoc Thai; 1978 Jun; 61(6):330-9. PubMed ID: 670850
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of clofibrate on flow cytometric populations in rat liver.
    Tomioka Y; Suzuki H; Miura K; Yamaguchi T; Hishinuma T; Mizugaki M
    Methods Find Exp Clin Pharmacol; 1996 Apr; 18(3):189-95. PubMed ID: 8738070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulatory effect of clofibrate and gemfibrozil administration on the formation of fatty acid esters of estradiol by rat liver microsomes.
    Xu S; Zhu BT; Conney AH
    J Pharmacol Exp Ther; 2001 Jan; 296(1):188-97. PubMed ID: 11123380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypolipidemic activity of glycine and its derivatives].
    Ryzhenkov VE; MolokovskiÄ­ DS; Ioffe DV
    Vopr Med Khim; 1984; 30(2):78-80. PubMed ID: 6740998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of carbon tetrachloride induced hepatotoxicity by dantrolene sodium.
    Steinhauer LS; Joyave JL; Davidson CP; Born CK; Hamrick ME
    Res Commun Chem Pathol Pharmacol; 1986 Apr; 52(1):59-70. PubMed ID: 3012725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hypolipidemic drugs on the expression of genes involved in high density lipoprotein metabolism in the rat.
    Staels B; Van Tol A; Fruchart JC; Auwerx J
    Isr J Med Sci; 1996 Jun; 32(6):490-8. PubMed ID: 8682657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clofibrate treatment promotes branched-chain amino acid catabolism and decreases the phosphorylation state of mTOR, eIF4E-BP1, and S6K1 in rat liver.
    Ishiguro H; Katano Y; Nakano I; Ishigami M; Hayashi K; Honda T; Goto H; Bajotto G; Maeda K; Shimomura Y
    Life Sci; 2006 Jul; 79(8):737-43. PubMed ID: 16616211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative biochemical and ultrastructural study of the hepatic response induced in the rat by 2 hypolipemic agents: clofibrate and itanoxone].
    Gendre PM; Marcelon G; Delhon A; Lauressergues H; Fauran F
    J Pharmacol; 1984; 15(2):209-22. PubMed ID: 6738078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypolipidemic activity of some derivatives of 6H-dibenzo[b,d]pyran.
    Banzatti C; Branzoli U; Lovisolo PP; Melloni P; Orsini G; Salvadori P
    Arzneimittelforschung; 1984; 34(8):864-9. PubMed ID: 6541922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peroxisomes and hypolipidemic agents ].
    Heller F; Pourbaix S
    Sem Hop; 1982 Jul; 58(28-29):1712-7. PubMed ID: 6289453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in hepatic carnitine acetyltransferase activity associated with peroxisomal (microbody) proliferation induced by the hypolipidemic drugs clofibrate, nafenopin, and methyl clofenapate.
    Moody DE; Reddy JK
    Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):501-10. PubMed ID: 4445568
    [No Abstract]   [Full Text] [Related]  

  • 16. Liver parenchymal cell injury. IV. Pattern of incorporation of carbon and chlorine from carbon tetrachloride into chemical constituents of liver in vivo.
    Reynolds ES
    J Pharmacol Exp Ther; 1967 Jan; 155(1):117-26. PubMed ID: 6017333
    [No Abstract]   [Full Text] [Related]  

  • 17. Stimulatory effect of clofibrate on the action of estradiol in the mammary gland but not in the uterus of rats.
    Xu S; Zhu BT; Cai MX; Conney AH
    J Pharmacol Exp Ther; 2001 Apr; 297(1):50-6. PubMed ID: 11259527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome enzyme modification and oxidative stress in rat by hypolipidemic and antiinflammatory drugs.
    Rivero A; Monreal JI; Gil MJ
    Rev Esp Fisiol; 1994 Dec; 50(4):259-68. PubMed ID: 7754169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased hepatotoxicity of carbon tetrachloride by the hypolipidemic drug nafenopin in rats.
    Charpentier D; Tuchweber B
    Res Commun Chem Pathol Pharmacol; 1982 Jun; 36(3):449-61. PubMed ID: 6289397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of clofibrate, silybin, safflower oil and lamindran on liver peroxisome proliferation and enzyme activities in rats].
    Wu SG; Shen YA; Zheng Z; Long K
    Zhongguo Yao Li Xue Bao; 1986 May; 7(3):283-4. PubMed ID: 2954381
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.